HealthcareServices

Metabolomics Market Report 2026: Strategic Insights and Revenue Outlook

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the metabolomics market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Metabolomics Market from 2026 to 2030?

The metabolomics market size has experienced significant expansion in recent years. It is projected to increase from $4.17 billion in 2025 to $4.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.5%. The historical growth can be ascribed to several factors, including the acceleration of biomarker discovery research, greater adoption of mass spectrometry, a surge in cancer metabolism studies, the broadening use of chromatography systems, and the evolution of metabolite profiling techniques.

The metabolomics market size is projected for significant growth over the next few years, reaching $9.29 billion in 2030, propelled by a compound annual growth rate (CAGR) of 17.3%. This expansion during the forecast period is driven by factors such as advancements in bioinformatics tools, an increasing focus on personalized medicine, growing demand for nutrigenomics applications, development in metabolic pathway research, and broader integration into clinical diagnostics. Prominent trends expected in this period include the merging of precision medicine with metabolomic profiling, the expansion of cloud-based metabolomics data platforms, AI-driven metabolite pattern recognition, enhanced automation in high-throughput metabolomics workflows, and IoT-enabled real-time metabolic monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

What Drivers Are Affecting Demand In The Metabolomics Market?

The expanding occurrence of cancer is projected to fuel the advancement of the metabolomics market. Cancer encompasses a range of illnesses characterized by the uncontrolled proliferation of abnormal cells, their invasion into tissues, and potential dissemination to other parts of the body. The increasing frequency of cancer is primarily linked to the aging population, given that advanced age constitutes the most significant risk factor for developing the majority of cancer types, with most instances affecting individuals over 65 years old. Metabolomics assists cancer investigations by delivering a comprehensive insight into metabolic alterations within tumor cells, facilitating early diagnosis, deciphering disease mechanisms, and pinpointing prospective therapeutic targets. For example, in February 2024, the World Health Organization, an international body based in Switzerland focused on global health policies, forecasted over 35 million new cancer cases by 2050, representing a 77% rise from the approximately 20 million cases in 2022. Consequently, the growing incidence of cancers is stimulating expansion within the metabolomics market.

Which Segment Groups Are Influencing The Metabolomics Market?

The metabolomics market covered in this report is segmented –

1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications

3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Subsegments:

1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance)

2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services

Which Market Trends Are Opening Growth Opportunities In The Metabolomics Market?

Leading companies in the metabolomics market are prioritizing the introduction of Integrated Bioinformatics Platforms to enhance the understanding of complex metabolomic data, thereby driving advancements in personalized medicine, biomarker discovery, and disease insights. An Integrated Bioinformatics Platform is defined as a comprehensive software solution that merges various bioinformatics tools and databases to streamline the analysis and interpretation of biological information. Researchers are able to index metabolomics data against Metabolon’s precise biochemical pathway maps, which aids in uncovering biological processes and disease mechanisms. For instance, in February 2024, Metabolon, Inc., a US-based company, unveiled Metabolon’s bioinformatics platform. The Biomarker Lenses feature within the Integrated Bioinformatics Platform allows users to apply advanced analytical filters to concentrate on metabolites connected to specific pathways or diseases, enabling a more targeted exploration of metabolomic data. Furthermore, the platform offers tools for conducting statistical analyses such as T-tests and ANOVAs, providing researchers with the ability to construct and compare statistical models, manage metadata, and effectively visualize results.

Who Are The Primary Competitors In The Global Metabolomics Market?

Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Metabolomics Market?

North America was the largest region in the metabolomics market in 2025. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Metabolomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2497&type=smp

Browse Through More Reports Similar to the Global Metabolomics Market 2026, By The Business Research Company

Proteomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Metagenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795